|
UTP23 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.022000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.007800E-01 |
| Normal-vs-Stage2 |
2.537800E-01 |
| Normal-vs-Stage3 |
1.495540E-03 |
| Normal-vs-Stage4 |
1.062670E-03 |
| Stage1-vs-Stage2 |
8.261200E-01 |
| Stage1-vs-Stage3 |
1.991540E-02 |
| Stage1-vs-Stage4 |
1.809540E-02 |
| Stage2-vs-Stage3 |
3.448200E-01 |
| Stage2-vs-Stage4 |
2.772000E-01 |
| Stage3-vs-Stage4 |
7.836000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.200440E-02 |
| Normal-vs-AfricanAmerican |
1.75175000000083E-05 |
| Normal-vs-Asian |
8.973800E-01 |
| Caucasian-vs-AfricanAmerican |
5.718100E-03 |
| Caucasian-vs-Asian |
5.147000E-01 |
| AfricanAmerican-vs-Asian |
5.541700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.320700E-03 |
| Normal-vs-Female |
3.755800E-02 |
| Male-vs-Female |
5.332400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.164400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.464000E-02 |
| Normal-vs-Age(61-80Yrs) |
8.200100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.404350E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.467400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.218000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.752600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.690600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.162400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.965800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.406200E-01 |
| Normal-vs-Grade 2 |
4.523800E-01 |
| Normal-vs-Grade 3 |
4.94110000004433E-06 |
| Normal-vs-Grade 4 |
2.021200E-04 |
| Grade 1-vs-Grade 2 |
2.230600E-01 |
| Grade 1-vs-Grade 3 |
3.238300E-03 |
| Grade 1-vs-Grade 4 |
9.897800E-03 |
| Grade 2-vs-Grade 3 |
3.71490000000696E-05 |
| Grade 2-vs-Grade 4 |
1.615560E-03 |
| Grade 3-vs-Grade 4 |
5.306600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.993400E-01 |
| Normal-vs-ccB subtype |
8.158500E-03 |
| ccA subtype-vs-ccB subtype |
1.172140E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.057840E-02 |
| Normal-vs-N1 |
5.795600E-02 |
| N0-vs-N1 |
6.198200E-01 |
|
|
